Clinical Trial Update: Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA [Phase 2]

View source ↗

Summary

A Phase 2 study exploring meditation effects on brain activity in Parkinson disease using FDOPA imaging has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Andrew Newberg | Conditions: Parkinson Disease, Idiopathic Parkinson Disease | Phase 2 | Status: WITHDRAWN